Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs > Compugen (CGEN)

Yep its posted:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DAD2 Member Profile
 
Followed By 66
Posts 5,006
Boards Moderated 0
Alias Born 03/11/09
160x600 placeholder
Compugen to Present at Oppenheimer 25th Annual Healthcare Conference "Business Wire" - 12/3/2014 7:01:00 AM
Compugen Announces Experimental Confirmation of Additional Methodology for Discovery of Cancer-Related Immune Checkpoints "Business Wire" - 12/2/2014 7:07:00 AM
Compugen to Present at Jefferies 2014 Global Healthcare Conference in London "Business Wire" - 11/12/2014 7:01:00 AM
Compugen Ltd. Reports Third Quarter 2014 Financial Results "Business Wire" - 10/29/2014 7:13:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/29/2014 7:07:45 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/28/2014 7:02:43 AM
Compugen Discloses Successful Validation Results for Novel B7/CD28–like Cancer Immunotherapy Target Candidate "Business Wire" - 10/27/2014 7:01:00 AM
Compugen Third Quarter 2014 Conference Call Scheduled for Wednesday, October 29, 2014 at 10:00 AM ET "Business Wire" - 10/22/2014 7:11:00 AM
Compugen Achieves Second Preclinical Milestone in Cancer Immunotherapy Collaboration with Bayer "Business Wire" - 10/14/2014 2:02:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/14/2014 1:49:35 PM
Compugen Immune Checkpoint Results Being Presented at Three Scientific Conferences "Business Wire" - 10/6/2014 7:08:00 AM
Compugen Discloses New Results for Novel Target Candidate for Cancer Immunotherapy "Business Wire" - 10/1/2014 7:01:00 AM
Compugen Announces Presentations of Results for CGEN-15001 Supporting Immune Tolerance Induction "Business Wire" - 9/29/2014 7:04:00 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 9/5/2014 6:00:20 AM
Prospectus Filed Pursuant to Rule 424(b)(2) (424b2) "Edgar (US Regulatory)" - 9/4/2014 4:46:16 PM
Securities Registration (foreign Private Issuer) (f-3) "Edgar (US Regulatory)" - 8/26/2014 4:06:25 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/26/2014 4:02:33 PM
Compugen Appoints Mr. Ari Krashin as Chief Financial Officer "Business Wire" - 8/25/2014 7:09:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/25/2014 7:01:31 AM
Compugen Reacquires Baize’s Financial Interest in Pipeline Product Candidates "Business Wire" - 8/21/2014 7:09:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/21/2014 7:01:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/11/2014 7:00:02 AM
Compugen Ltd. Reports 2nd Quarter 2014 Financial Results "Business Wire" - 8/6/2014 7:11:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/6/2014 7:00:28 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 7/31/2014 4:15:40 PM
DAD2   Tuesday, 02/07/12 07:23:17 AM
Re: Penny Roger$ post# 111
Post # of 144 
Yep its posted:

Zero revenues in the 4th quarter and the net loss for the 4th quarter was $4.4 million.

Might pull back slightly imo.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist